Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00203775
Status:
TERMINATED
Last Update Posted:
2006-10-13
First Post:
2005-09-12
Brief Title:
Haloperidol vs Risperidone in the Treatment of Aggression in Psychotic Inmates
Sponsor:
University of Connecticut
Organization:
UConn Health
Study Overview
Official Title:
Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates
Status:
TERMINATED
Status Verified Date:
2005-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates It is hypothsized that risperdal will be more effective in decreasing aggression than haldol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| RIS-USA-T255 | None | None | None |
| IRB Project Number 01-250 | None | None | None |